vTv Therapeutics Inc. (CIK: 0001641489) EDGAR, Information, Filings... CompaniesBIO.Com

vTv Therapeutics Inc.

Mailing address
3980 PREMIER DR, SUITE 310, HIGH POINT, Delaware, 27265
Phone
336-841-0300
State location
North Carolina
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS
Filings
N/A

vTv Therapeutics Inc. (CIK: 0001641489) is an American company incorporated in the state of North Carolina. Head office is located at 3980 PREMIER DR, SUITE 310, HIGH POINT, North Carolina, 27265. Work in the industry 2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS. vTv Therapeutics Inc. is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
Tuch Steven L.	0001957337	Dec-08-2022	officer: Chief Financial Officer
Isaacsohn Jonathan	0001943095	Aug-09-2022	director
SEKHRI PAUL J	0001264519	Aug-01-2022	director, officer: President and CEO
Al-Marzooqi Fahed	0001928247	Jul-13-2022	director
Harris Keith R.	0001742703	Jul-11-2022	director
KOZLOV HERSH	0001228774	Jul-01-2022	director
Weiner Howard L.	0001710056	Jul-01-2022	director
Harjivan Chandresh	0001932607	Jun-01-2022	director
G42 Investments AI Holdings RSC Ltd.	0001931913	May-31-2022	director, 10 percent owner
Al-Nahyan Tahnoon Bin Zayed S.	0001934660	May-31-2022	10 percent owner
Brown Barry K.	0001903270	Mar-29-2022	officer: Chief Accounting Officer
Nelson Rich S.	0001833145	Mar-03-2022	director, officer: Acting Chief Executive Officer
Prasad Deepa	0001867165	Oct-19-2021	director, officer: President and CEO
Abrams Robin Elizabeth	0001671781	Dec-30-2020	director
Taibi Edward P.	0001820265	Aug-31-2020	director
HOWARD RUDY	0001108161	Mar-10-2017	officer: CFO & Secretary
KINDLER JEFFREY B	0001174454	Mar-10-2017	director, officer: Executive Chairman
Holcombe Stephen L.	0001648953	Mar-10-2017	officer: President & CEO
Parker Craig C	0001526064	May-12-2016	director
FRY JOHN A	0001255140	Mar-16-2016	director
ALTSTIEL LARRY DOUGLAS	0001619444	Dec-01-2015	officer: Chief Medical Officer
Spiegel Noel Joseph	0001513234	Nov-19-2015	director
SAVAS PAUL G	0001275756	Sep-25-2015	director
PERELMAN RONALD O	0001186472	Sep-22-2015	10 percent owner
MEISTER PAUL M	0001033876	Jul-30-2015	director
Cohen Steven Michael	0001648881	Jul-30-2015	director

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by vTv Therapeutics Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
8-K	Document	Current report filing Acc-no: 0001641489-24-000063 (34 Act) Size: KB	Aug-08-2024	001-37524 241188869
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001641489-24-000061 (34 Act) Size: KB	Aug-08-2024	001-37524 241188712
8-K	Document	Current report filing Acc-no: 0001641489-24-000057 (34 Act) Size: KB	Jul-26-2024	001-37524 241147143
8-K	Document	Current report filing Acc-no: 0001641489-24-000054 (34 Act) Size: KB	Jul-02-2024	001-37524 241096280
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-078626 ( Act) Size: 0 KB	Jun-27-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001641489-24-000051 ( Act) Size: 0 KB	Jun-27-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001641489-24-000049 ( Act) Size: 0 KB	Jun-27-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001641489-24-000047 ( Act) Size: 0 KB	Jun-27-2024
8-K	Document	Current report filing Acc-no: 0001641489-24-000045 (34 Act) Size: KB	Jun-14-2024	001-37524 241045164
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001415889-24-016730 ( Act) Size: 0 KB	Jun-13-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001641489-24-000042 ( Act) Size: 0 KB	Jun-13-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001641489-24-000040 ( Act) Size: 0 KB	Jun-13-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001641489-24-000039 ( Act) Size: 0 KB	Jun-13-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001641489-24-000038 ( Act) Size: 0 KB	Jun-13-2024
3	Document	Initial statement of beneficial ownership of securities Acc-no: 0001641489-24-000037 ( Act) Size: 0 KB	Jun-13-2024
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001641489-24-000029 (34 Act) Size: KB	May-09-2024	001-37524 24931295
8-K	Document	Current report filing Acc-no: 0001641489-24-000027 (34 Act) Size: KB	May-09-2024	001-37524 24931171
EFFECT	Document	Acc-no: 9999999995-24-001186 (33 Act) Size: KB	Apr-29-2024	333-278612 24893809
424B2	Document	Prospectus filed pursuant to Rule 424(b)(2) Acc-no: 0001193125-24-122473 (33 Act) Size: KB	Apr-29-2024	333-278612 24891425
424B2	Document	Prospectus filed pursuant to Rule 424(b)(2) Acc-no: 0001193125-24-122412 (33 Act) Size: KB	Apr-29-2024	333-278612 24891350

Recent 20 filings. View all vTv Therapeutics Inc. filings

Overall rating 5.0

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

vTv Therapeutics Inc. overview
vTv Therapeutics Inc. job
vTv Therapeutics Inc. stock
vTv Therapeutics Inc. ownership
vTv Therapeutics Inc. CEO
vTv Therapeutics Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.